Supplementary Table 1. Baseline characteristics of patients with dermatomyositis who received COVID-19 vaccination by disease flare status

Published: 21 September 2022| Version 1 | DOI: 10.17632/783fstrwtm.1
Contributors:
Catherina Pan,
, Daniel Kim, Rachael Rowley, Morgan Shaefer, Avery LaChance, Vinod Nambudiri

Description

Characteristics of patients with dermatomyositis who did and did not have disease flare after COVID-19 vaccination

Files

Categories

Dermatology, Dermatomyositis, Vaccination, COVID-19

Licence